It is difficult to estimate the risk of hemorrhage that may follow an invasive or
surgical procedure in patients with thrombocytopenia or platelet dysfunction. Conventional
functional tests for the evaluation of primary hemostasis have been questioned. We
have evaluated the in vitro bleeding time (IVBT) using the Thrombostat 4000 in 25
patients with thrombocytopenia in order to estimate the risk of bleeding following
an invasive or surgical procedure. Using the IVBT, it was possible to suggest and
evaluate preoperative treatment in order to restore primary hemostasis. All patients
studied had their operations without bleeding complications. From these observations
we conclude that the IVBT is a convenient and useful tool in the evaluation of primary
hemostasis in these patients.
Keywords
bleeding time - Thrombostat 4000 - thrombocytopenia - surgery - platelets